Medications with Generic Name Beginning ‘S’, Page 40

Page 40 of 386 « First Page « … 5 10 15 20 25 … 38 39 40 41 42 … 45 50 55 60 65 … » Last Page »

Sertraline

Sertraline hydrochloride tablets are indicated for the treatment of the following [See Clinical Studies (14)]: Major depressive disorder (MDD). Obsessive-compulsive disorder (OCD). Panic…

Quality Care Products, LLC10 December 2018

SERTRALINE

Sertraline tablets are indicated for the treatment of the following [See Clinical Studies (14). ]: Major depressive disorder (MDD). Obsessive-compulsive disorder (OCD). Panic disorder…

Exelan Pharmaceuticals, Inc.29 November 2018

Sertraline

Sertraline hydrochloride tablets are indicated for the treatment of the following [See Clinical Studies (14)]: Major depressive disorder (MDD). Obsessive-compulsive disorder (OCD). Panic…

Contract Pharmacy Services-PA29 December 2018

SERTRALINE

Sertraline tablets are indicated for the treatment of the following [See Clinical Studies (14). ]: Major depressive disorder (MDD). Obsessive-compulsive disorder (OCD). Panic disorder…

A-S Medication Solutions29 April 2019

Sertraline

Sertraline hydrochloride tablets are indicated for the treatment of the following [See Clinical Studies (14)]: Major depressive disorder (MDD). Obsessive-compulsive disorder (OCD). Panic…

Legacy Pharmaceutical Packaging, LLC18 July 2019

Page 40 of 386 « First Page « … 5 10 15 20 25 … 38 39 40 41 42 … 45 50 55 60 65 … » Last Page »

FDA Medwatch

BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
Sun, 20 Sep 2020. Three of the recalls, which BD announced on Aug. 4, 2020, have been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means that FDA has determined that there is a reasonable probability that the use of the product…
Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
Wed, 16 Sep 2020. Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.